Free tool
FAERS Monitor: Potassium Chloride 20meq In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019904 or its brand name (Potassium Chloride 20meq In Plastic Container, Potassium Chloride). Reports on generic versions are filed under their own applications.
Reports
93,810
Serious
69,872
74% of reports
Hospitalization
43,158
Death reported
13,688
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- diarrhoea6,883
- dyspnoea6,837
- nausea6,626
- fatigue6,413
- death4,665
- pneumonia4,544
- headache4,281
- vomiting4,214
- asthenia4,206
- off label use4,119
- dizziness4,050
- pain3,918
- fall3,687
- drug ineffective3,638
- anaemia3,172
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 901 |
| 2005 | 1,824 |
| 2006 | 1,348 |
| 2007 | 1,683 |
| 2008 | 2,435 |
| 2009 | 2,665 |
| 2010 | 2,185 |
| 2011 | 2,586 |
| 2012 | 3,567 |
| 2013 | 2,072 |
| 2014 | 2,479 |
| 2015 | 3,923 |
| 2016 | 4,697 |
| 2017 | 4,797 |
| 2018 | 5,789 |
| 2019 | 5,658 |
| 2020 | 5,668 |
| 2021 | 6,017 |
| 2022 | 6,667 |
| 2023 | 6,693 |
| 2024 | 7,494 |
| 2025 | 7,576 |
| 2026 | 5,080 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,960,349 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| anaemiaSignal | 3,172 | 3.8 | 3.6 | 6,419 |
| pneumoniaSignal | 4,544 | 3.2 | 3.1 | 6,787 |
| dyspnoeaSignal | 6,837 | 2.7 | 2.7 | 7,600 |
| astheniaSignal | 4,206 | 2.5 | 2.5 | 3,899 |
| fallSignal | 3,687 | 2.5 | 2.4 | 3,334 |
| diarrhoeaSignal | 6,883 | 2.4 | 2.4 | 5,769 |
| vomitingSignal | 4,214 | 2.0 | 2.0 | 2,195 |
| nausea | 6,626 | 1.9 | 1.8 | 2,833 |
| fatigue | 6,413 | 1.9 | 1.8 | 2,596 |
| dizziness | 4,050 | 1.8 | 1.8 | 1,540 |
| headache | 4,281 | 1.5 | 1.5 | 816 |
| pain | 3,918 | 1.4 | 1.4 | 524 |
| death | 4,665 | 1.2 | 1.2 | 184 |
| off label use | 4,119 | 1.1 | 1.0 | 12 |
| drug ineffective | 3,638 | 0.6 | 0.6 | 914 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.